Alex

Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.
news_6

In Support of the International Summer Games in Tokyo, Everbridge Providing New Risk Data Intelligence Feed to Safeguard Visitors, Business Operations, and Traveling Workers

Leveraging its Market-leading Global Network of over 25,000 Security Threat Data Sources, Everbridge’s Latest Situational Awareness Reporting Helps Organizations Prepare...

news_6

Arcturus Announces Approval of a Clinical Trial Application to Advance ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting the SARS-CoV-2 Delta Variant and Other Variants of Concern

news_6

CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Accepted by China’s National Medical Products Administration

BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--CANbridge Pharmaceuticals Inc., a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development...

news_6

IASO Biotherapeutics’ World’s First Fully Human CD19/CD22 Dual-Targeted CAR-T Drug Receives Two IND Clearances, Enters Clinical Trials

NMPA’s Clearance of CT120 Marks Major Milestone in Treatment for B-Cell Malignancies PLEASANTON, Calif. & NANJING, China & SHANGHAI--(BUSINESS WIRE)--#Biopharmaceutical--IASO...